ICAM1 and neoplasm: Moreover, it interferes with the infiltration and delivery of functional T cells towards the tumor, downregulates the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), and develops the loss of antitumor immunity and immunotherapeutic resistance (77).